195 related articles for article (PubMed ID: 35246487)
1. Inflammatory markers in saliva and urine reflect disease activity in patients with systemic lupus erythematosus.
Ruacho G; Lira-Junior R; Gunnarsson I; Svenungsson E; Boström EA
Lupus Sci Med; 2022 Mar; 9(1):. PubMed ID: 35246487
[TBL] [Abstract][Full Text] [Related]
2. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
[TBL] [Abstract][Full Text] [Related]
3. Interferon-Inducible Protein 10 and Disease Activity in Systemic Lupus Erythematosus and Lupus Nephritis: A Systematic Review and Meta-Analysis.
Puapatanakul P; Chansritrakul S; Susantitaphong P; Ueaphongsukkit T; Eiam-Ong S; Praditpornsilpa K; Kittanamongkolchai W; Avihingsanon Y
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31597273
[TBL] [Abstract][Full Text] [Related]
4. Serum TWEAK as a biomarker for disease activity of systemic lupus erythematosus.
Choe JY; Kim SK
Inflamm Res; 2016 Jun; 65(6):479-88. PubMed ID: 26921306
[TBL] [Abstract][Full Text] [Related]
5. Macrophage colony-stimulating factor could evaluate both disease activity and renal involvement in systemic lupus erythematosus.
Wang R; Zhao H; Liu Y; Li Y; Cai J
Ann Palliat Med; 2021 Feb; 10(2):2098-2107. PubMed ID: 33549023
[TBL] [Abstract][Full Text] [Related]
6. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
Mirioglu S; Cinar S; Yazici H; Ozluk Y; Kilicaslan I; Gul A; Ocal L; Inanc M; Artim-Esen B
Lupus; 2020 Apr; 29(4):379-388. PubMed ID: 32041504
[TBL] [Abstract][Full Text] [Related]
7. TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus.
Idborg H; Eketjäll S; Pettersson S; Gustafsson JT; Zickert A; Kvarnström M; Oke V; Jakobsson PJ; Gunnarsson I; Svenungsson E
Lupus Sci Med; 2018; 5(1):e000260. PubMed ID: 29955370
[TBL] [Abstract][Full Text] [Related]
8. Serum IP-10 is useful for identifying renal and overall disease activity in pediatric systemic lupus erythematosus.
Zhang CX; Cai L; Shao K; Wu J; Zhou W; Cao LF; Chen TX
Pediatr Nephrol; 2018 May; 33(5):837-845. PubMed ID: 29264699
[TBL] [Abstract][Full Text] [Related]
9. Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis.
Abujam B; Cheekatla S; Aggarwal A
Lupus; 2013 May; 22(6):614-23. PubMed ID: 23629827
[TBL] [Abstract][Full Text] [Related]
10. Increased Immunoglobulin Gamma-3 Chain C in the Serum, Saliva, and Urine of Patients with Systemic Lupus Erythematosus.
Jung JY; Kim JW; Lee SW; Baek WY; Kim HA; Suh CH
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108090
[TBL] [Abstract][Full Text] [Related]
11. S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus.
Kim JW; Jung JY; Lee SW; Baek WY; Kim HA; Suh CH
Front Immunol; 2022; 13():886209. PubMed ID: 35529863
[TBL] [Abstract][Full Text] [Related]
12. Serum and Urinary Interferon-Gamma-Inducible Protein 10 in Lupus Nephritis.
El-Gohary A; Hegazy A; Abbas M; Kamel N; Nasef SI
J Clin Lab Anal; 2016 Nov; 30(6):1135-1138. PubMed ID: 27184880
[TBL] [Abstract][Full Text] [Related]
13. IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
Yoshio T; Okamoto H; Kurasawa K; Dei Y; Hirohata S; Minota S
Lupus; 2016 Aug; 25(9):997-1003. PubMed ID: 26846690
[TBL] [Abstract][Full Text] [Related]
14. Serum and urinary galectin-9 and C-X-C motif chemokine ligand 10.
Mehta P; Singh P; Aggarwal A
Lupus; 2022 Apr; 31(4):482-487. PubMed ID: 35245170
[TBL] [Abstract][Full Text] [Related]
15. Salivary biomarkers of inflammation in systemic lupus erythematosus.
Stanescu II; Calenic B; Dima A; Gugoasa LA; Balanescu E; Stefan-van Staden RI; Baicus C; Badita DG; Greabu M
Ann Anat; 2018 Sep; 219():89-93. PubMed ID: 29621567
[TBL] [Abstract][Full Text] [Related]
16. Monocyte chemoattractant protein-1 as a marker of systemic lupus erythematosus: an observational study.
Živković V; Cvetković T; Mitić B; Stamenković B; Stojanović S; Radovanović-Dinić B; Jurišić V
Rheumatol Int; 2018 Jun; 38(6):1003-1008. PubMed ID: 29181621
[TBL] [Abstract][Full Text] [Related]
17. Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort.
Willis R; Seif AM; McGwin G; Martinez-Martinez LA; González EB; Dang N; Papalardo E; Liu J; Vilá LM; Reveille JD; Alarcón GS; Pierangeli SS
Lupus; 2012 Jul; 21(8):830-5. PubMed ID: 22343096
[TBL] [Abstract][Full Text] [Related]
18. IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus.
Rose T; Grützkau A; Hirseland H; Huscher D; Dähnrich C; Dzionek A; Ozimkowski T; Schlumberger W; Enghard P; Radbruch A; Riemekasten G; Burmester GR; Hiepe F; Biesen R
Ann Rheum Dis; 2013 Oct; 72(10):1639-45. PubMed ID: 23117242
[TBL] [Abstract][Full Text] [Related]
19. Cytokine and Chemokine Concentration in the Tear of Patients with Age-Related Cataract.
Engelbrecht C; Sardinha LR; Rizzo LV
Curr Eye Res; 2020 Sep; 45(9):1101-1106. PubMed ID: 31928443
[TBL] [Abstract][Full Text] [Related]
20. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]